192 related articles for article (PubMed ID: 10225963)
21. New protein steals the show as 'costimulator' of T cells.
Cohen J
Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
[No Abstract] [Full Text] [Related]
22. Review of CTLA4Ig use for allograft immunosuppression.
Lin H; Wei RQ; Gordon D; Linsley P; Turka LA; Bolling SF
Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114
[No Abstract] [Full Text] [Related]
23. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated gene transfer of CTLA4Ig to liver allografts results in prolonged survival and local T-cell anergy.
Olthoff KM; Da Chen X; Gelman A; Turka L; Shaked A
Transplant Proc; 1997; 29(1-2):1030-1. PubMed ID: 9123183
[No Abstract] [Full Text] [Related]
25. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
26. CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers.
Wallace PM; Johnson JS; MacMaster JF; Kennedy KA; Gladstone P; Linsley PS
Transplantation; 1994 Sep; 58(5):602-10. PubMed ID: 8091487
[TBL] [Abstract][Full Text] [Related]
27. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen.
Lew AM; Brady JL; Silva A; Coligan JE; Georgiou HM
Transplantation; 1996 Jul; 62(1):83-9. PubMed ID: 8693551
[TBL] [Abstract][Full Text] [Related]
28. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
Wu Y; Guo Y; Liu Y
J Exp Med; 1993 Nov; 178(5):1789-93. PubMed ID: 8228824
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppression of direct T-cell-mediated xenorecognition in vitro.
Rogers NJ; Mirenda V; Jackson I; Dorling A; Lechler RI
Transplant Proc; 2001; 33(1-2):697-8. PubMed ID: 11267024
[No Abstract] [Full Text] [Related]
30. The role of CTLA-4 in the regulation and initiation of T-cell responses.
Chambers CA; Krummel MF; Boitel B; Hurwitz A; Sullivan TJ; Fournier S; Cassell D; Brunner M; Allison JP
Immunol Rev; 1996 Oct; 153():27-46. PubMed ID: 9010718
[No Abstract] [Full Text] [Related]
31. CTLA-4, a negative regulator of T-lymphocyte activation.
Waterhouse P; Marengère LE; Mittrücker HW; Mak TW
Immunol Rev; 1996 Oct; 153():183-207. PubMed ID: 9010724
[No Abstract] [Full Text] [Related]
32. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.
Schwartz RH
Cell; 1992 Dec; 71(7):1065-8. PubMed ID: 1335362
[No Abstract] [Full Text] [Related]
33. Costimulatory regulation of T cell function.
Chambers CA; Allison JP
Curr Opin Cell Biol; 1999 Apr; 11(2):203-10. PubMed ID: 10209159
[TBL] [Abstract][Full Text] [Related]
34. CTLA-4: new insights into its biological function and use in tumor immunotherapy.
Egen JG; Kuhns MS; Allison JP
Nat Immunol; 2002 Jul; 3(7):611-8. PubMed ID: 12087419
[TBL] [Abstract][Full Text] [Related]
35. The radiation-sensitive costimulatory factors involved in B-cell-dependent T-cell activation by minor lymphocyte stimulating antigen.
Chow K; Fu J; Kong H; Jiang S; Chang KS; Shih CC
J Biomed Sci; 1998; 5(5):332-42. PubMed ID: 9758907
[No Abstract] [Full Text] [Related]
36. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease.
Lee YH; Miki T; Kuddus R; Tandin A; Goller AL; Subbotin V; Fung JJ; Peach R; Valdivia LA; Rao AS
Transplant Proc; 2000 Aug; 32(5):1032-3. PubMed ID: 10936336
[No Abstract] [Full Text] [Related]
37. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
Lin H; Wei RQ; Goodman RE; Bolling SF
Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
[TBL] [Abstract][Full Text] [Related]
38. CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.
Chambers CA; Allison JP
Cold Spring Harb Symp Quant Biol; 1999; 64():303-12. PubMed ID: 11232300
[No Abstract] [Full Text] [Related]
39. Lymphocyte activation: T-cell regulation by CTLA-4.
Linsley PS; Golstein P
Curr Biol; 1996 Apr; 6(4):398-400. PubMed ID: 8723343
[No Abstract] [Full Text] [Related]
40. Humanized monoclonals and other biological initiatives.
Halloran PF; Prommool S
Clin Biochem; 1998 Jul; 31(5):353-7. PubMed ID: 9721434
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
